Hospital-associated infections can be better identified and contained through technology, a multi-institutional team reports.
MR-PET imaging can reveal inflammation and neurodegeneration in the brain, among other things, and a recent study showed that it can also help determine the progression of multiple sclerosis (MS).
With some patients being treated for multiple sclerosis with Aubagio for more than a decade questions have been raised about the safety of the treatment for such a long period of time. Further research has shown it to still be safe for the people who need it most.
It can be easy to look at the treatment of multiple sclerosis and stop at the physical symptoms of the disease. For patients living with the condition their daily lives are about more than the symptoms and making them work within their own individual challenges.
A recent review article provided updated information on classification systems, preventive techniques, pathophysiological mechanisms, and treatment options for postoperative ileus.
A research team from Johns Hopkins Hospital in Baltimore, MD, set out to identify factors associated with variation in hospital hepatopancreatobiliary surgery charges.
Magnetic resonance imaging (MRI) can be used to identify lesions in the central nervous system in patients with multiple sclerosis (MS), but not all patients with active disease have identifiable lesions, and researchers are mixed over the extent to which lesions can be used as a marker for MS disease activity.
The panelists enumerate some potential future interventions being tested for COPD, including stem cells for lung regeneration, and provide their final thoughts to conclude this program.
We all know that many interventions can improve lung function, but can any of them slow the inevitable decline in lung function that happens with COPD?